Search

Author/Creator Dong, Yingwen

2. Dexpramipexole effects on functional decline and survival in subjects with amyotrophic lateral sclerosis in a Phase II study: Subgroup analysis of demographic and clinical characteristics. Issue 1 (January 2013)

Authors:
Rudnicki, Stacy A.; Berry, James D.; Ingersoll, Evan; Archibald, Don; Cudkowicz, Merit E.; Kerr, Douglas A.; Dong, Yingwen
Journal:
Amyotrophic lateral sclerosis and frontotemporal degeneration
Issue:
Volume 14:Issue 1(2013)
Page Start:
44
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study. Issue 1 (20th January 2022)

Authors:
Zucali, Paolo Andrea; Lin, Chia-Chi; Carthon, Bradley C; Bauer, Todd M; Tucci, Marcello; Italiano, Antoine; Iacovelli, Roberto; Su, Wu-Chou; Massard, Christophe; Saleh, Mansoor; Daniele, Gennaro; Greystoke, Alastair; Gutierrez, Martin; Pant, Shubham; Shen, Ying-Chun; Perrino, Matteo; Meng, Robin;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The Combined Assessment of Function and Survival (CAFS): A new endpoint for ALS clinical trials. Issue 3 (April 2013)

Authors:
Berry, James D.; Miller, Robert; Moore, Dan H.; Cudkowicz, Merit E.; Van Den Berg, Leonard H.; Kerr, Douglas A.; Dong, Yingwen; Ingersoll, Evan W.; Archibald, Donald
Journal:
Amyotrophic lateral sclerosis and frontotemporal degeneration
Issue:
Volume 14:Issue 3(2013)
Page Start:
162
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗